During the session on Vaccines, Basic and Translational Research at the Third Research Meeting on Melanoma, Milan, Italy, held in May 2003, many questions regarding the development of new immunotherapeutical strategies for the treatment of melanoma and more basic research on tumorigenesis, as well as new prognostic markers for disease progression, were addressed. This report briefly summarizes some of the highlights and themes of this session.
Copyright 2004 Lippincott Williams & Wilkins